chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.33
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV1
Symptoms: Infant irritability, Injection site rash, Pyrexia, Rash, Skin warm
Clinical narrative: Bumps all over body, crying and fever, received immunizations 2/15  Patient at home with mom.Patient had 4 mos vaccines ( 2nd series, OK last time) on 2/15/23.That afternoon , patient given bath with new soap with oat exract, and lotion with oatmilk and dimethicone. That night patient had fever " 105F" forehead temp , only forehead is hot , body not flushed or hot . Rx Tylenol, fever went down to 102F after 1 hr . Next day 12/16/23, no more fever , but noted rash on legs, then spreads to body today 2/17/23, few rashes on face, Slight fussy but eats OK . No other symptoms . Assessments 1. Rash and other nonspecific skin eruption - R21 (Primary) 2. Postvaccination fever - R50.83 Treatment 1. Rash and other nonspecific skin eruption  Start Benadryl Allergy Liquid, 12.5 MG/5ML, 2.5 ml, Orally, every 6 hrs as needed, 7 days, 100 Notes: stop all products with dimethicone and oat extract. OK sensitive soap/ wash.  ________________________________________________________ Date: 02/21/2023     Time: 08:48 AM spoke to mom to follow up on Fever/rash dicussed through video visit on 2/17 mom stated patients sxs are completely resolved picked up Benadryl rx sent on 2/17 the next day on 2/18 states fever stopped since then Rash looked better on Sunday 2/19 and woke up Monday 2/20 with rash completely resolved Mother offered no further concerns at this time.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 4/15/21 Lot# Ew0150;  Pfizer 5/6/21 Lot# Ew0164;  Pfizer 12/30/21 Lot# 33036BD
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 2/19/21 Lot# 023M20A;  MOderna 3/19/21 Lot# 002B21A;  Moderna 11/2/21 Lot# 077C21B
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 3/18/21 Lot# 044A21A;  Moderna 4/15/21 Lot# 025B21A
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 4/16/21 Lot# Ew0158;  Pfizer 5/13/21 Lot# EW0186
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration.
Age: 34.0
Sex: F
Vaccine: VARCEL
Symptoms: Incorrect route of product administration
Clinical narrative: Vaccine administered IM route. Per standing order vaccine not to be re-administered. Patient counseled that vaccine does not need to be re-administered.
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: Pt's parent wrote the date of birth for their child on the consent form incorrectly but the real birthday for the child is one year difference. The patient was four years old receiving a 5-11 year old monovalent Pfizer. The parent has been notified that the child should have not received this vaccine at four years of age.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration.
Age: 98.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Asthenia, Confusional state, Gait disturbance, Irritability
Clinical narrative: MENTAL CONFUSION, DIFFICULTY WALKING, IRRITABLE, WEAKNESS, MEMORY LOSS
Age: 87.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 5 vaccines Pfizer 2/23/21 Lot# El9267;  Pfizer 3/16/21 Lot# EN6205;  Pfizer 12/14/21 Lot# FD7218;  Moderna 4/21/22  Lot# 042J21A;  Moderna 9/23/22 Lot# AS7146B
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: The parent who filled out the child's consent form wrote the date of birth as but the real birthday is, meaning that the patient was 4 years of age at the time of vaccination for the 5-11 monovalent Pfizer. I spoke with the patient over the phone and let her know that the child was given a 5-11 pfizer.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Moderna 2/4/21 Lot# 013M20A;  Moderna 3/4/21 Lot# 030A21A;  Moderna 11/23/21 Lot# 012H21B;  Moderna 7/27/22 Lot# 006M21A
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Loss of consciousness, Mental status changes, Respiratory distress
Clinical narrative: 3RD DOSE PFIZER COVID VACCINE GIVEN 9/28/21, #30145BA 4TH DOSE PFIZER COVID VACCINE GIVEN 7/23/22, #FP7135 pt brought from SNF by EMS due to altered mental status, unconscious, respiratory distress; pt positive for COVID; papers sent with EMS to hospital stating pt is DNR, comfort measures only; pt passed away in the ED.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: 3RD DOSE PFIZER COVID VACCINE GIVEN 9/28/21, #30145BA 4TH DOSE PFIZER COVID VACCINE GIVEN 7/23/22, #FP7135 pt brought from SNF by EMS due to altered mental status, unconscious, respiratory distress; pt positive for COVID; papers sent with EMS to hospital stating pt is DNR, comfort measures only; pt passed away in the ED.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 4/30/21 Lot# Ew0172;  Pfizer 6/1/21 Lot# Ew0186
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dizziness, Pallor, Presyncope
Clinical narrative: My daughter woke up pale.  Her stomach has been hurting her since Sunday.  She had a dizzy spell and almost blacked out in school
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 5 vaccines Pfizer 2/27/21 Lot# EN6202;  Pfizer 3/20/21 Lot# EN6207;  Pfizer 10/9/21 Lot# FF8841;  Pfizer 5/31/22 Lot# FN2908;  Pfizer 9/13/22 Lot# GJ2524
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 2/4/21 Lot# 013M20A;  Moderna 3/4/21 Lot# 030A21A;
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 6/24/21 Lot# EW0196;  Pfizer 7/15/21 Lot# E0196
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Paralysis
Clinical narrative: Stroke. Paralethis of one side of body.  Not treated immediatly due to age. ER visit when moved to assisted living.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines ; Moderna 3/31/21 Lot# 017B21A;  Moderna 4/26/21 006C21A
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 2/21/21 Lot# 005M20A;  Moderna 3/12/21 Lot# 002B21A
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 3/31/21 Lot# ER8730;  Pfizer 4/21/21 Lot# Ew0162; Pfizer 11/21/21 Lot# FH8027
Age: 4.0
Sex: F
Vaccine: HIBV
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reaction, the vaccine was expired by 6 days at the time, i spoke with the family same day and again 2/21/23 and patient is fine, Vaccine administered on 2/17/23, exp date of vaccine was 2/11/23
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Extra dose administered, Product administration error
Clinical narrative: administration error..6 doses given
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Endotracheal intubation, General physical health deterioration, Intensive care
Clinical narrative: pt taken to ED at a local Medical Center with SOB; required intubation emergently; transferred to another hospital for higher level of care; transferred to ICU; able to be weaned from ventilator and extubated; work of breathing increased and pt declined; transitioned to DNR/DNI, comfort measures; pt passed away in the hospital
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Mechanical ventilation
Clinical narrative: pt taken to ED at a local Medical Center with SOB; required intubation emergently; transferred to another hospital for higher level of care; transferred to ICU; able to be weaned from ventilator and extubated; work of breathing increased and pt declined; transitioned to DNR/DNI, comfort measures; pt passed away in the hospital
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 2/24/21 Lot# El9267;  Pfizer 3/17/21 Lot# EN6205;  Pfizer 12/20/21 Lot# FL3197
Age: 84.0
Sex: F
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Administered a second Pfizer COVID Bivalent vaccine after patient received one on 9-3-22.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 2/6/21 Lot# 011M20A;  Moderna 3/6/21 Lot# 030A21A;
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 55.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cardiac arrest, Dyspnoea, Pulseless electrical activity
Clinical narrative: Pulseless electrical activity, Cardiac arrest, possible PE event, pt spouse reported shortness of breath 3-4 days prior to incident with no recent illness per hospital report.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 4/16/21 Lot# Ew0162;  Pfizer 5/7/21 Lot# Ew0164
Age: 28.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Pain, Pyrexia, Skin warm
Clinical narrative: Redness, warmth, pain, and fever. Non- steroidal resolving.   Date seen by dr.  2/17/23
Age: 50.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood test abnormal, Condition aggravated, Fatigue, Psoriasis, Psoriatic arthropathy
Clinical narrative: Worsening/flare of plaque psoriasis skin symptoms and onset of psoriatic arthritis symptoms including enthesis pain at tendon insertion points and fatigue.  It should be stated that psoriasis skin symptoms were present BEFORE any COVID vaccinations, but enthesis and fatigue were not.   I was diagnosed officially on 2/20/2023 with psoriatic arthritis. I do not know if it is related to the COVID vaccine, but I did question it because the pain began in the tendons in the arm in which I received the shot, and fatigue began just a week or two after receiving the 4th dose, bivalent booster.
Age: 50.0
Sex: F
Vaccine: COVID19-2
Symptoms: Tendon pain, X-ray abnormal
Clinical narrative: Worsening/flare of plaque psoriasis skin symptoms and onset of psoriatic arthritis symptoms including enthesis pain at tendon insertion points and fatigue.  It should be stated that psoriasis skin symptoms were present BEFORE any COVID vaccinations, but enthesis and fatigue were not.   I was diagnosed officially on 2/20/2023 with psoriatic arthritis. I do not know if it is related to the COVID vaccine, but I did question it because the pain began in the tendons in the arm in which I received the shot, and fatigue began just a week or two after receiving the 4th dose, bivalent booster.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 7/15/21 LOt# EW0169 Pfizer 8/5/21 Lot# Ew0169
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Moderna 3/13/21 Lot# 002B21A;  Moderna 4/10/21 Lot# 025B21A;  Moderna 11/27/21 Lot# 027H21B;  Moderna 4/12/22 Lot# 065K21A
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Asthenia, COVID-19, COVID-19 pneumonia
Clinical narrative: pt admitted to hospital with AHRF secondary to COVID pneumonia; positive for COVID; severe sepsis; acute multiorgan failure; poor oral intake; generalized weakness; placed on BiPAP; acute hepatitis secondary COVID infection; acute on chronic renal failure; HTN; given IV ABX, Dexamethasone; IV fluids; pt's condition worsened; AMS, lethargy; CT showed acute CVA secondary to COVID infection; transitioned pt to DNR, comfort care; pt passed away in the hospital
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Computerised tomogram head abnormal, Death, General physical health deterioration, Hepatitis acute
Clinical narrative: pt admitted to hospital with AHRF secondary to COVID pneumonia; positive for COVID; severe sepsis; acute multiorgan failure; poor oral intake; generalized weakness; placed on BiPAP; acute hepatitis secondary COVID infection; acute on chronic renal failure; HTN; given IV ABX, Dexamethasone; IV fluids; pt's condition worsened; AMS, lethargy; CT showed acute CVA secondary to COVID infection; transitioned pt to DNR, comfort care; pt passed away in the hospital
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension, Hypophagia, Lethargy, Mental status changes, Multiple organ dysfunction syndrome
Clinical narrative: pt admitted to hospital with AHRF secondary to COVID pneumonia; positive for COVID; severe sepsis; acute multiorgan failure; poor oral intake; generalized weakness; placed on BiPAP; acute hepatitis secondary COVID infection; acute on chronic renal failure; HTN; given IV ABX, Dexamethasone; IV fluids; pt's condition worsened; AMS, lethargy; CT showed acute CVA secondary to COVID infection; transitioned pt to DNR, comfort care; pt passed away in the hospital
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, SARS-CoV-2 test positive, Sepsis
Clinical narrative: pt admitted to hospital with AHRF secondary to COVID pneumonia; positive for COVID; severe sepsis; acute multiorgan failure; poor oral intake; generalized weakness; placed on BiPAP; acute hepatitis secondary COVID infection; acute on chronic renal failure; HTN; given IV ABX, Dexamethasone; IV fluids; pt's condition worsened; AMS, lethargy; CT showed acute CVA secondary to COVID infection; transitioned pt to DNR, comfort care; pt passed away in the hospital
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 1/5/21 Lot# 025J20A;  Moderna 2/2/21 Lot# 011L20A
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines ;Moderna 1/29/21 NO LOT #;  Moderna 2/26/21 Lot# 015M20A ; Moderna 10/23/21 Lot# 041C21A
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: Computerised tomogram head abnormal, Migraine
Clinical narrative: Migraine 8 days later on October 6, 2022.  Migraine has been persistent since that day. Now working with neurologist to find medication. Also, trying to control with diet.  Was not immediately diagnosed as a migraine until after about a month of evaluation (CT scans of brain and sinuses, course of antibiotics and prednisone while waiting for doctor appointments).  Neurologist dismissed as vaccine-related, but I thought it was really coincidental and thought it should be reported. I only had possibly one migraine-like episode March 2, 2022, but it resolved within approximately 3 days.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines pfizer 8/31/21 Lot# FC3182;  Pfizer 9/21/21 Lot# 301358A
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines  Moderna 2/9/21 Lot# 031L20A;  Moderna 3/9/21 Lot# 032M20A;  Moderna 10/27/21 Lot# 076C21A
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: given bivalent COVID 19 booster for dose #1 of primary series. CDC site recommended giving correct primary dose. Patient informed of situation and agreed to receive second injection as suggested. instructed to return for further vaccines
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic spontaneous urticaria, Urticaria
Clinical narrative: Broke out in hives on 8/7/2022.  Required several courses of prednisone and numerous antihistamines to gain control.  Ultimately diagnosed with chronic idiopathic urticaria.  Still has mild episodes of hives intermittently.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 2/24/21 Lot# EN6200;  Pfizer 3/17/21 Lot# ER2613;  Pfizer 10/26/21 Lot# NOT LISTED
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chest X-ray normal, Culture negative, Encephalopathy, Leukocytosis, Pyrexia
Clinical narrative: sepsis syndrome with encephalopathy, fever, leukocytosis. all cultures and CXR negative, no infection discovered
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Sepsis
Clinical narrative: sepsis syndrome with encephalopathy, fever, leukocytosis. all cultures and CXR negative, no infection discovered
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines' Pfizer 1/6/22 Lot# 33130BA;  Pfizer 2/10/22 Lot# FJ6369
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines  Pfizer 5/24/21 Lot# Ew0172;  Pfizer 7/7/21 Lot# Ew0173
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 7/2/21 Lot# Ew0172;  PFIZEr 7/30/21  Lot# EW0173;
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Autopsy, COVID-19, Death, SARS-CoV-2 test positive, Toxicity to various agents
Clinical narrative: no medical records on this patient; COD:  acute drug toxicity complicating COVID 19; PCR post-mortem COVID test showed "probable"; ME reviewed autopsy report and considered COVID death; if had not had COVID, the pt likely would not have died
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 3/22/21 Lot# ER2613; Pfizer 4/12/21 Lot# Ew0150
Age: 46.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient came in to receive their first pfizer covid shot. They instead received the new pfizer updated bivalent booster. patewint reported no adverse reactions. They only needed to verify they would be able to get fully vaccinated before they leave on a cruise trip
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines 3/23/21 Pfizer LOt# ER2613;  4/13/21 PfizerLot# EW0150
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, COVID-19, Dysuria, SARS-CoV-2 test positive
Clinical narrative: Hospitalization: 1/20/2023 - 1/22/2023 (2 days) Presentation to the ED: increasing abd pain and trouble urinating.  COVID + date: 1/20/23 Treatment: Did not require treatment.  Discharge to: home.   040C21A 7/23/2021 004F21A 8/21/2021
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Syncope
Clinical narrative: Hospitalization: 1/20/2023 - 1/22/2023 (2 days) Presentation to the ED: syncopal episode COVID + date: 1/20/2023 Treatment: no treatment required. Discharge to: HOME.   EN6200 3/1/2021 EN6199 3/23/2021
Age: 85.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: Hospitalization: 1/21/2023 - 2/14/2023 (24 day) Presentation to the ED:  COVID + date: 1/21/23 Treatment: Decadron & remdesivir Discharge to:   001A21A 3/6/2021 047A21A 4/3/2021
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: Hospitalization: 1/15/2023 - 1/23/2023 (8 days) Presentation to the ED: AMS COVID + date: 1/27/2023 Treatment: remdesivir and decadron Discharge to: hospice. patient expired 1/27/2023.   022M20A 3/12/2021 038B21A 4/15/2021
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 4 vaccines Pfizer 2/23/21 Lot# EN6200;  Pfizer 3/16/21 Lot# En6207;  Pfizer 8/24/21 Lot# Ew0173;  Pfizer 4/9/22 Lot# FP4554
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Asthenia, COVID-19, Oedema peripheral, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Hospitalization: 1/20/2023 - 1/24/2023 (4 days) Presentation to the ED: fevers, bilateral lower extremity edema, and weakness. admitted for sepsis. COVID + date: 1/24/2023 Treatment: none. patient was found positive on a transfer screen to hospital.  Discharge to:   EN6200 2/19/2021 EN6206 3/13/2021 32030BD 11/12/2021 010H22A 1/6/2023
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Sepsis
Clinical narrative: Hospitalization: 1/20/2023 - 1/24/2023 (4 days) Presentation to the ED: fevers, bilateral lower extremity edema, and weakness. admitted for sepsis. COVID + date: 1/24/2023 Treatment: none. patient was found positive on a transfer screen to hospital.  Discharge to:   EN6200 2/19/2021 EN6206 3/13/2021 32030BD 11/12/2021 010H22A 1/6/2023
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Hospitalization: 1/24/2023 - 1/25/2023 (29 hours) Presentation to the ED: worsening symptoms: cough, sore throat, fever.   COVID + date: 1/24/2023 Treatment: none. patient was stable on room air.  Discharge to: home.  031L20A 2/4/2021 027A21A 3/8/2021
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine given to patient. Per CDC recommendations, will revaccinate.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, UNK
Symptoms: COVID-19, SARS-CoV-2 test positive, Transient ischaemic attack
Clinical narrative: Hospitalization: 1/20/2023 - 1/24/2023 (4 days) Presentation to the ED: Admitted for transient ischemic attack COVID + date: 1/22/2023 Treatment: No indication for antiviral or steroids therapy.  Discharge to: SNF  EN5318 1/29/2021 EN6200 2/20/2021 32030BD 11/1/2021
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Death, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Hospitalization: 1/16/2023 - 1/25/2023 (9 days) Presentation to the ED: hypoxia COVID + date: 1/16/2023 Treatment: remdesivir & Decadron Discharge to: home with hospice. patient expired 1/30/2023.   038K20A 2/2/2021 031M20A 3/2/2021 051F21A 11/6/2021
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Hospitalization: 1/26/2023 - 1/29/2023 (3 days) Presentation to the ED: shortness of breath and hypoxemia.  COVID + date: 1/26/2023 Treatment: remdesivir and steroids and o2 supplementation. Discharge to: home.  044A21A 3/10/2021 046B21A 4/12/2021 032H21A 12/13/2021
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitalization: 1/29/2023 - 1/31/2023 (2 days) Presentation to the ED: intractable abdominal discomfort COVID + date: 1/22/2023 Treatment: NONE. PATIENT WAS PREVIOUSLY TREATED AND NOT ELLIGIBLE FOR ADDITIONAL TREATMENT.  Discharge to: home.  EN6200 2/19/2021 EN6206 3/13/2021
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Deep vein thrombosis
Clinical narrative: DVT and PE
Age: 87.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Anaemia, Asymptomatic COVID-19, Cerebrovascular accident, Death, Haemoglobin decreased
Clinical narrative: Hospitalization: 1/30/2023 - 2/4/2023 (5 days) Presentation to the ED: Presented to the ED due to anemia with hemoglobin 5.2 noted at outpatient/rehab facility where she was recovering from a stroke. COVID + date: 1/30/2023. Treatment: NO TREATMENT REQUIRED. PATIENT WAS NOT SYMPTOMATIC. Discharged: PATIENT LATER EXPIRED ON 2/17/2023. 002A21A 2/24/2021 017B21A 3/29/2021 035C21A 10/26/2021 AS7146B 10/22/2022
Age: 87.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Hospitalization: 1/30/2023 - 2/4/2023 (5 days) Presentation to the ED: Presented to the ED due to anemia with hemoglobin 5.2 noted at outpatient/rehab facility where she was recovering from a stroke. COVID + date: 1/30/2023. Treatment: NO TREATMENT REQUIRED. PATIENT WAS NOT SYMPTOMATIC. Discharged: PATIENT LATER EXPIRED ON 2/17/2023. 002A21A 2/24/2021 017B21A 3/29/2021 035C21A 10/26/2021 AS7146B 10/22/2022
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asymptomatic COVID-19, Dizziness, SARS-CoV-2 test positive, Vertigo
Clinical narrative: Hospitalization: 1/30/2023 - 1/31/2023 (27 hours) Presentation to the ED: dizziness and vertigo symptoms concerning for possible CVA COVID + date: 1/30/2023 Treatment: ASYMPTOMATIC. NO TREATMENT REQUIRED. Discharge to: HOME.   006B21A 3/17/2021 037B21A 4/17/2021 001J212A 1/8/2022
Age: 80.0
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, UNK, UNK
Symptoms: COVID-19, Respiratory distress, SARS-CoV-2 test positive
Clinical narrative: Hospitalization: 1/31/2023 - 2/10/2023 (10 days) Presentation to the ED: respiratory distress COVID + date: 1/31/23 Treatment: bronchodilators.  Discharge to: home. 002A21A 3/12/2021 046B21A 4/9/2021 035C21A 11/19/2021 002M21A 4/28/2022
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest pain, Diarrhoea, Dyspnoea, Nausea
Clinical narrative: Hospitalization: 2/2/2023 - 2/5/2023 (3 days); Presentation to the ED: shortness of breath, chest pain and nausea vomiting and diarrhea. COVID + date: 2/2/23. Treatment: Azithromycin and Rocephin, bronchodilator.  Discharge to: home. 038K20A 1/29/2021; 013M20A 2/26/2021.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting
Clinical narrative: Hospitalization: 2/2/2023 - 2/5/2023 (3 days); Presentation to the ED: shortness of breath, chest pain and nausea vomiting and diarrhea. COVID + date: 2/2/23. Treatment: Azithromycin and Rocephin, bronchodilator.  Discharge to: home. 038K20A 1/29/2021; 013M20A 2/26/2021.
Age: 3.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was given the wrong formulation of the vaccine. She was due for the second monovalent in the series for the pediatric 6m-4years Pfizer Covid vaccine but received a Bivalent dose instead. I contacted Ask the Experts from the CDC and they advised the 3rd dose also be the Bivalent 6m-4years.  Parent reported zero side effects from the vaccine.
Age: 84.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Muscular weakness, SARS-CoV-2 test positive
Clinical narrative: Hospitalization: 1/30/2023 - 2/2/2023 (3 days) Presentation to the ED: BLE WEAKNESS COVID + date: 2/2/23. Treatment: NONE. PATIENT WAS DISCOVERED POSITIVE ON A TRANSFER SCREEN TO hospital.  Discharge to:   046A21A 3/31/2021 039B21A 4/28/2021 031H21A 11/20/2021
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: Per CDC guidelines, patient continued series with primary series shot. only adverse reaction was the patient being concerned of not being fully vaccinated to take a cruise trip
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Death, Pneumonia, SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: Hospitalization: 2/4/2023 - 2/8/2023 (4 days) Presentation to the ED: BILATERAL PNEUMONIA & UTI. COVID + date: 2/4/23. Treatment: steroids  Discharge to: HOSPICE - EXPIRED 2/9/23. 038K20A 1/29/2021 023M20A 2/26/2021 047C21A 11/4/2021 027L21A 4/13/2022
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death, Respiratory disorder, SARS-CoV-2 test positive
Clinical narrative: Hospitalization: 2/4/2023 - 2/7/2023 (3 days) Presentation to the ED: worsening respiratory status.  COVID + date: 2/4/23. Treatment: no treatment specific to COVID.  Discharge to: hospice - expired 2/7/23.  002A21A 2/25/2021 017B21A 3/30/2021
Age: 7.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, Injection site pain
Clinical narrative: Pfizer Bivalent vaccine for ages 5-11 was administered in error to patient. Patient was due for second dose of Pfizer primary for ages 5-11. A vial of the Bivalent vaccine was placed in the box for the Primary vaccines by another unknown employee on a previous date. The family was notified. Per CDC guidelines, no follow up treatment is due at this time. Also per CDC guidelines, the patient is able to be scheduled for Pfizer Bivalent booster dose in 8 weeks. Patient reports no reaction or symptoms besides the expected soreness at injection site.
Age: 33.0
Sex: F
Vaccine: PNC20
Symptoms: Lymphadenopathy, Rash, Swelling, Swelling face
Clinical narrative: facial swelling, rash and neck swelling/lymphadenopathy
Age: 25.0
Sex: M
Vaccine: COVID19-2
Symptoms: C-reactive protein increased, Chest pain, Echocardiogram abnormal, Musculoskeletal pain, Pericardial effusion
Clinical narrative: 1/10: Began to experience chest pain w/ exertion (running on treadmill). Chest pain would stop w/o exertion. Intermittent chest pain over the next course of 2 weeks. 1/26: Left sided chest pain, constant, radiating to L shoulder blade and down arm.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient received monovalent Pfizer vaccine when patient should have received Bivalent pfizer vaccine. patient was unharmed, no symptoms of reaction. Patient will return in 8 weeks to receive bivalent dose
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Pt received Moderna for the first two primary doses. Third dose was given on 2/17/23. This dose was Pfizer.
Sex: U
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus  Brief course of steroid orally No change
Age: 65.0
Sex: F
Vaccine: UNK
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site hypoaesthesia, Injection site induration, Injection site pruritus
Clinical narrative: The area of the shot feels numb and "muscle hard"  to the touch, and it's a bit reddish and itchy for a week.  It's been a week and it still feels itchy and sensitive to the touch, slightly red on the skin compared to the other arm
Age: 0.33
Sex: M
Vaccine: DTAPIPV
Symptoms: Decreased appetite, Hypersomnia, Infant irritability
Clinical narrative: Patient had some fussiness, sleeping more and decreased appetite, 24 hours after vaccine. Spoke with mother to see how patient was doing. Mother stated he was doing better.
Age: 81.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Patient reports a little swelling and pain the following day on 2/15, which has persisted and has stayed "tender to the touch/sore around the site" for the past week. The swelling grew to the point of about a baseball, and has since progressively decreased to about the size of a golf ball. Today on 2/21/23 it has decreased to about the size of a pea, but it is still red, tender, and warm to the touch.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration.
Age: 41.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Moderna Monovalent 0.25 mL was administered as booster dose instead of Moderna Bivalent 0.5 mL. Pt. tolerated well, there was no adverse reaction at time of vaccination and after. Once error was caught by RN Manager - pt. was contacted and made aware of the above.
Age: 11.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Burning sensation, Erythema, Pain in extremity, Pruritus, Skin warm
Clinical narrative: REDNESS,WARMTH,ITCHING,BURNING,RASH,PAIN THROUGHOUT ARM NOTED THE FOLLOWING DAY AFTER ADMINISTRATION MOTHER ADMINISTERED ADVIL
Age: 59.0
Sex: M
Vaccine: PPV
Symptoms: Extra dose administered
Clinical narrative: Patient received a dose of  Pneumovax 23 on September 30, 2020 due to being a smoker.  He received a second dose on October 14, 2021 - which was not indicated per protocol.
Age: 77.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site rash
Clinical narrative: red, warm, itchy, sore, rash at injection site lasting for at least a week. pt had shingrix vaccine in other arm same day and time and no adverse reactions from that one
Age: 72.0
Sex: M
Vaccine: PPV
Symptoms: Adverse reaction, Extra dose administered
Clinical narrative: PATIENT HAD PREVIOUSLY RECEIVED 1 DOSE OF PNEUMOVAX 23 ON 11/10/2018 AND RECEIVED AN ANOTHER ONE ON 9/14/2021. PATIENT STATED HE HAD A REACTION BUT COULD NOT REMEMBER SINCE IT WAS LONG AGO.
Age: 24.0
Sex: M
Vaccine: COVID19-2
Symptoms: Wrong product administered
Clinical narrative: Patient?s first time obtaining any Covid Primary series and was provided the Moderna Bivalent dosage.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle discomfort, Neuralgia
Clinical narrative: following the initial injection on my left arm, i notice later in the day (about 30 minutes later) i felt a strange sensation in the muscle area just below my left thumb on my hand.  feels like soreness on one of the nerves that is running through there.  the pain comes and goes and is not consistent through out the day.  some days there is no pain at all, but some days the pain returns randomly.  (these strange sensations went away about a month afterwards)  But then eventually it comes back every once in a while. Fast forward to the last couple of months, i started feeling the the light nerve pain again.  but this time it seems like the pain spot has moved slightly upwards my left thumb.  (there are no regular patterns as to when the pain come and go) i mentioned it to my general medicine doctor, he said to just keep an eye on it and did not provide any resolutions at all.
Age: 37.0
Sex: M
Vaccine: COVID19-2, COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Autoimmune hepatitis, Biliary tract disorder, Biopsy bile duct abnormal
Clinical narrative: Patient developed acute liver injury with transminitis to 900ss ALT, 1000s AST, TBili low 20s at peak. This was thought to be secondary to autoimmune hepatitis based upon initial biopsy results. This began within 2 weeks of vaccination based on history, although patient is not exactly sure when his initial symptoms were.
Age: 37.0
Sex: M
Vaccine: COVID19-2, COVID19
Symptoms: Blood alkaline phosphatase increased, Blood bilirubin increased, Blood lactate dehydrogenase increased, Cholangitis, Hepatic necrosis
Clinical narrative: Patient developed acute liver injury with transminitis to 900ss ALT, 1000s AST, TBili low 20s at peak. This was thought to be secondary to autoimmune hepatitis based upon initial biopsy results. This began within 2 weeks of vaccination based on history, although patient is not exactly sure when his initial symptoms were.
Age: 37.0
Sex: M
Vaccine: COVID19-2, COVID19
Symptoms: Hypertransaminasaemia, Liver injury
Clinical narrative: Patient developed acute liver injury with transminitis to 900ss ALT, 1000s AST, TBili low 20s at peak. This was thought to be secondary to autoimmune hepatitis based upon initial biopsy results. This began within 2 weeks of vaccination based on history, although patient is not exactly sure when his initial symptoms were.
Age: 37.0
Sex: M
Vaccine: COVID19-2, COVID19
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Autoimmune hepatitis, Biopsy liver abnormal, Blood alkaline phosphatase increased
Clinical narrative: Patient developed acute liver injury with transminitis to 900ss ALT, 1000s AST, TBili low 20s at peak. This was thought to be secondary to autoimmune hepatitis based upon initial biopsy results. This began within 2 weeks of vaccination based on history, although patient is not exactly sure when his initial symptoms were.
Age: 37.0
Sex: M
Vaccine: COVID19-2, COVID19
Symptoms: Blood bilirubin increased, C-reactive protein normal, Exposure to communicable disease, Faeces discoloured, Jaundice
Clinical narrative: Patient developed acute liver injury with transminitis to 900ss ALT, 1000s AST, TBili low 20s at peak. This was thought to be secondary to autoimmune hepatitis based upon initial biopsy results. This began within 2 weeks of vaccination based on history, although patient is not exactly sure when his initial symptoms were.
Age: 37.0
Sex: M
Vaccine: COVID19-2, COVID19
Symptoms: Respiratory symptom, Serum ferritin increased
Clinical narrative: Patient developed acute liver injury with transminitis to 900ss ALT, 1000s AST, TBili low 20s at peak. This was thought to be secondary to autoimmune hepatitis based upon initial biopsy results. This began within 2 weeks of vaccination based on history, although patient is not exactly sure when his initial symptoms were.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lethargy, Malaise, Pyrexia, Tinnitus
Clinical narrative: Mild fever, chills, lethargy, malaise - lasted 24 hours Tinnitus in both ears - still present with no abatement (almost 2 years later)
Age: 21.0
Sex: F
Vaccine: TDAP
Symptoms: Dizziness, Fatigue, Oropharyngeal pain, Pyrexia
Clinical narrative: - high fever (102.3) - sore throat - dizziness/lightheadedness - fatigue
Age: 13.0
Sex: M
Vaccine: FLU4, HPV9, MNQ
Symptoms: Disorientation, Fall, Feeling abnormal, Loss of consciousness, Memory impairment
Clinical narrative: Five minutes after the administration of the vaccines, the patient fainted and lost consciousness. He fell over to his left side onto the table. He then has a brief (five-six) second episode of shaking. After this, he regained consciousness, but was dazed and disoriented. We laid him back on the table and observed him for a few minutes. He appeared stable, but did not immediately recall what happened to him. We then call the paramedics who transported him to the nearest hospital  about a half mile away.
Age: 13.0
Sex: M
Vaccine: FLU4, HPV9, MNQ
Symptoms: Syncope, Tremor
Clinical narrative: Five minutes after the administration of the vaccines, the patient fainted and lost consciousness. He fell over to his left side onto the table. He then has a brief (five-six) second episode of shaking. After this, he regained consciousness, but was dazed and disoriented. We laid him back on the table and observed him for a few minutes. He appeared stable, but did not immediately recall what happened to him. We then call the paramedics who transported him to the nearest hospital  about a half mile away.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: Adult dose of Comirnaty Pfizer COVID vaccine
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Tinnitus
Clinical narrative: Fatigue - resolved within 24 hours Tinnitus in both ears - never resolved/no abatement
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Expired product administered
Clinical narrative: Vaccine was expired. exp. date 01/15/22
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to excursion temperature prior to vaccine administration.
Age: 45.0
Sex: M
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: The patient had previously received and Moderna Bivalent Covid-19 booster on 11/11/2022 and I mistakenly gave him an additional Moderna Bivalent Covid-19 booster dose.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Adenocarcinoma of colon, Anaemia, Colectomy, Colonoscopy abnormal, Computerised tomogram abdomen abnormal
Clinical narrative: Patient found to be anemic on 9/21/22 duriing routine blood work.  Further screening deteremined that he had Invasive Adenocarcinoma of the colon, Stage II.  Colon resection on 1/31/2023.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test abnormal
Clinical narrative: Patient found to be anemic on 9/21/22 duriing routine blood work.  Further screening deteremined that he had Invasive Adenocarcinoma of the colon, Stage II.  Colon resection on 1/31/2023.
Age: 75.0
Sex: M
Vaccine: FLU4
Symptoms: Pain, Pain in extremity
Clinical narrative: Deep soreness in all of left arm, pain in motion
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, COVID-19, Intensive care, SARS-CoV-2 test positive
Clinical narrative: Patient received Pfizer COVID vaccine on 2/1/21, 2/27/21, 11/1/21, 6/10/22, and Moderna bivalent COVID vaccine on 11/8/22. On 2/12/23, patient tested positive for COVID in her long-term care. On 2/14/23, patient admitted to our CCU for acute hypoxemic respiratory failure due to COVID-19. Patient transferred out to med/surg unit on 2/20/23. As of today (2/21/23), patient is still admitted in our med/surg unit.
Age: 11.0
Sex: F
Vaccine: MENB
Symptoms: No adverse event
Clinical narrative: no adverse event was noted, vaccine ordered in error
Age: 6.0
Sex: M
Vaccine: DTAPIPV, UNK
Symptoms: Culture throat negative, Extra dose administered, Oropharyngeal pain
Clinical narrative: The adverse event was that this patient received 4 yo vaccines that he had already received.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, COVID-19, Feeling cold, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: I experienced quite mild symptoms when I had my breakthrough case. They were cold-like symptoms, like a sore throat and a runny nose. At one point, I started to feel a chill, and that was when I realized it wasn't a cold. I took my temperature, which was a little higher than usual, but not too high. It was a while before I took a home antigen test, because on account of the mildness of the symptoms, it didn't occur to me that I might have had COVID-19. It was about the fourth day of my illness before I took a home test and got a positive result. I ended up taking about six home tests during my illness. They all yielded positive results until 12/31/2022, which was when I finally got a negative result for the first time.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: I experienced quite mild symptoms when I had my breakthrough case. They were cold-like symptoms, like a sore throat and a runny nose. At one point, I started to feel a chill, and that was when I realized it wasn't a cold. I took my temperature, which was a little higher than usual, but not too high. It was a while before I took a home antigen test, because on account of the mildness of the symptoms, it didn't occur to me that I might have had COVID-19. It was about the fourth day of my illness before I took a home test and got a positive result. I ended up taking about six home tests during my illness. They all yielded positive results until 12/31/2022, which was when I finally got a negative result for the first time.
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient needed first dose of Moderna Primary series however Bivalent was given. Patient was contacted and will be coming in 02/23/2023 for correct Moderna Primary Series. Patient does not report any adverse signs or symptoms.
Age: 15.0
Sex: M
Vaccine: FLU4
Symptoms: Asthenia, Blood glucose normal, Dizziness
Clinical narrative: /Patient received the flu shot at the office at  10:30Am, at around 10:38AM patient started to feel dizzy and weak. Blood pressure was  checked 95/56 heart rate was 46 and glucose was 104. Juice was given and after a few minutes patient started to feel better, Heart rate went up to 55. Patient was discharge home after being on observation and feeling better.
Age: 3.0
Sex: F
Vaccine: COVID19-2, HEPA
Symptoms: Wrong product administered
Clinical narrative: Bivalent vaccine was administered in error as a primary dose.
Age: 53.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood test, Cardiac monitoring abnormal, Cardiac stress test, Chest X-ray, Echocardiogram
Clinical narrative: Forty-eight hours post dose I began to experience multiple episodes of prolonged, rapid, and irregular heart rhythm at rest. I visited a local Urgent Care on Dec 6 who referred me to a cardiologist. I went to a local Cardiology office and was prescribed a heart monitor for 14 days that revealed multiple unexplained episodes of tachycardia. I saw my general practitioner, who referred me to another Dr who ordered  an echocardiogram and stress test. I also visited a local Hospital ER for chest X-ray and ECG
Age: 53.0
Sex: F
Vaccine: COVID19-2
Symptoms: Electrocardiogram, Heart rate abnormal, Heart rate increased, Heart rate irregular, Tachycardia
Clinical narrative: Forty-eight hours post dose I began to experience multiple episodes of prolonged, rapid, and irregular heart rhythm at rest. I visited a local Urgent Care on Dec 6 who referred me to a cardiologist. I went to a local Cardiology office and was prescribed a heart monitor for 14 days that revealed multiple unexplained episodes of tachycardia. I saw my general practitioner, who referred me to another Dr who ordered  an echocardiogram and stress test. I also visited a local Hospital ER for chest X-ray and ECG